These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8306563)

  • 1. Surveillance study adds to database on seroconversion rates and zidovudine use after occupational exposures.
    Clin Pharm; 1993 Sep; 12(9):636-7. PubMed ID: 8306563
    [No Abstract]   [Full Text] [Related]  

  • 2. Reported seroconversions to human immunodeficiency virus among workers worldwide--a review.
    Ricketts M; Deschamps L
    Can J Infect Control; 1992; 7(3):85-90. PubMed ID: 1482777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy.
    Winceslaus J
    Lancet; 1993 Jun; 341(8859):1537. PubMed ID: 8099408
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for occupational exposures to HIV.
    Paul SM; Jorden V; Costa SJ; Ziskin LZ
    N J Med; 1999 Jan; 96(1):41-6. PubMed ID: 9949657
    [No Abstract]   [Full Text] [Related]  

  • 5. Medically compromised patients, Part II. Current trends in zidovudine chemoprophylaxis post HIV exposure.
    Mito RS; Wahlers M
    J Calif Dent Assoc; 1995 Nov; 23(11):27-31. PubMed ID: 9051999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV and hepatitis C seroconversions in nurses].
    Lot F; Migueres B; Yazdanpanah Y
    Soins; 2002 Dec; (671):32-3. PubMed ID: 12599896
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy.
    Lancet; 1993 Apr; 341(8852):1077-8. PubMed ID: 8096971
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for occupational HIV.
    Nurs Stand; 1996 Jan; 10(19):28. PubMed ID: 8695409
    [No Abstract]   [Full Text] [Related]  

  • 9. Occupational health surveillance. We're making progress, but is it enough?
    Frye L
    AAOHN J; 1997 Apr; 45(4):184-7. PubMed ID: 9155268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive treatment urged for post-exposure therapy.
    AIDS Alert; 1997 Feb; 12(2):23-4. PubMed ID: 11364035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of occupational human immunodeficiency virus infection in health care workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV infection.
    Ippolito G; Puro V; De Carli G
    Arch Intern Med; 1993 Jun; 153(12):1451-8. PubMed ID: 8512436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated comprehensive occupational surveillance system for health care workers.
    Dement JM; Pompeii LA; Østbye T; Epling C; Lipscomb HJ; James T; Jacobs MJ; Jackson G; Thomann W
    Am J Ind Med; 2004 Jun; 45(6):528-38. PubMed ID: 15164397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New recommendations for prophylaxis after HIV exposure.
    Perlmutter BL; Harris BR
    Am Fam Physician; 1997 Feb; 55(2):507-12, 515-7. PubMed ID: 9054220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposures to blood in a dental teaching environment: results of a ten-year surveillance study.
    Younai FS; Murphy DC; Kotelchuck D
    J Dent Educ; 2001 May; 65(5):436-48. PubMed ID: 11425248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines.
    Glynn JR; Murray J; Bester A; Nelson G; Shearer S; Sonnenberg P
    AIDS; 2008 Sep; 22(14):1859-67. PubMed ID: 18753936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive therapy isn't a magic pill for exposures.
    AIDS Alert; 1997 Sep; 12(9):suppl 1-2. PubMed ID: 11364589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
    Rezza G; Galai N; Pezzotti P; Vlahov D; Graham NM; Viale P; Angarano G
    Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reported seroconversions to HIV.
    Roy E; Robillard P
    Can J Infect Control; 1993; 8(1):10. PubMed ID: 8324237
    [No Abstract]   [Full Text] [Related]  

  • 19. [Repeat estimate of the number of HIV-seropositive subjects in The Netherlands].
    van de Water HP; Bijleveld CC
    Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1115. PubMed ID: 1603173
    [No Abstract]   [Full Text] [Related]  

  • 20. Attitudes of HIV-positive women toward zidovudine therapy during pregnancy.
    J Adv Nurs; 2002 Sep; 39(5):410-1. PubMed ID: 12229862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.